Ultragenyx Pharmaceutical

Novato, United States

Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.

Nov 2025

Post-IPO Debt

Biotechnology Health Care Pharmaceutical

Top Investors

TakedaHealthCapTPG GrowthF-PrimeAdage Capital Management

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Ultragenyx Pharmaceutical

Who are Ultragenyx Pharmaceutical's investors?

Ultragenyx Pharmaceutical's investors include Takeda, HealthCap, TPG Growth, F-Prime, Adage Capital Management.

Where is Ultragenyx Pharmaceutical headquartered?

Ultragenyx Pharmaceutical is headquartered in Novato, United States.

What does Ultragenyx Pharmaceutical do?

Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.

What stage is Ultragenyx Pharmaceutical at?

Ultragenyx Pharmaceutical is at the Post-IPO Debt stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 4, 2025.

MLA

"Ultragenyx Pharmaceutical — Funding & Investors." VCBacked, November 4, 2025, https://www.vcbacked.co/company/ultragenyx-pharmaceutical. Accessed July 1, 2026.

APA

VCBacked. (2025). Ultragenyx Pharmaceutical — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/ultragenyx-pharmaceutical

Wikipedia (cite web)

{{cite web |title=Ultragenyx Pharmaceutical — Funding & Investors |url=https://www.vcbacked.co/company/ultragenyx-pharmaceutical |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 4, 2025.